Moreover, transgenic expression of NKp44 in mouse NK cells resulted in greater control of tumors expressing PDGF-DD showing that whilst PDGF-DD can support tumor growth it also exposes tumor cells to NK cell immunosurveillance via NKp44. The gene discussed is NCR2; the disease is neoplasm.